| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/05/2009 | US7527933 Genetic products differentially expressed in tumors and the use thereof |
| 05/05/2009 | US7527798 Composition and method for preventing or treating a virus infection |
| 05/05/2009 | US7527797 Capsular polysaccharide of Vibrio cholerae O139 covalently bound with an adipic acid dihydrazide linker to a recombinant diphtheria toxin carrier protein eliciting serum vibriocidal antibodies; conjugated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), |
| 05/05/2009 | US7527796 Constructing recombinant gene encoding immunoglobulin fusion for use in diagnosis, prevention and treatment of equine viral disease; veterinary medicine |
| 05/05/2009 | US7527791 Humanized anti-TGF-beta antibodies |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | US7527789 Use of a preparation based on an antibody directed against a tumor-associated glycosylation |
| 05/05/2009 | US7527788 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 05/05/2009 | US7527787 Multivalent immunoglobulin-based bioactive assemblies |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 05/01/2009 | CA2607771A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
| 04/30/2009 | WO2009055783A2 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 04/30/2009 | WO2009055711A2 Anti-rsv g protein antibodies |
| 04/30/2009 | WO2009055669A2 Monoclonal antibodies against activated and unactivated protein c |
| 04/30/2009 | WO2009055524A1 Methods of inhibiting viral infection |
| 04/30/2009 | WO2009055417A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | WO2009055074A2 Erbb2 binding proteins and use thereof |
| 04/30/2009 | WO2009054939A2 Cancer classification and methods of use |
| 04/30/2009 | WO2009054873A2 Anti-rantes antibodies and methods of use thereof |
| 04/30/2009 | WO2009054708A2 Antibody therapy for highly pathogenic avian influenza virus |
| 04/30/2009 | WO2009054435A1 Polypeptide having enhanced effector function |
| 04/30/2009 | WO2009054091A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | WO2009053987A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| 04/30/2009 | WO2009053696A1 Monoclonal antibody for app |
| 04/30/2009 | WO2009053637A2 Anti-ricin antibody |
| 04/30/2009 | WO2009053604A2 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 04/30/2009 | WO2009053514A1 Method for the diagnosis and treatment of diseases which develop with alteration of kinase p38, elements necessary therefor and applications thereof |
| 04/30/2009 | WO2009053512A1 Porcine torovirus proteins n, m and he, method for production thereof and uses thereof in diagnosis and treatment of porcine torovirus |
| 04/30/2009 | WO2009053481A1 Compositions and methods for modulating nk and t cell trafficking |
| 04/30/2009 | WO2009053442A1 Use of trkb antibodies for the treatment of respiratory disorders |
| 04/30/2009 | WO2009053368A1 Single ifn-beta fused to a mutated igg fc fragment |
| 04/30/2009 | WO2009053358A1 Method for purifying fc-fusion proteins |
| 04/30/2009 | WO2009053354A1 Use of tenascin-w as a biomarker for colon cancer |
| 04/30/2009 | WO2009052830A1 Novel antibody therapies |
| 04/30/2009 | WO2009052737A1 Medicament for preventing and controlling alzheimer's disease |
| 04/30/2009 | WO2009052628A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | WO2009052623A1 Therapeutic and diagnostic methods using tim-3 |
| 04/30/2009 | WO2009033742A3 Streptococcus pneumoniae vaccines |
| 04/30/2009 | WO2009033670A3 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 04/30/2009 | WO2009030237A3 Methods for recombinant manufacturing of anti-rsv antibodies |
| 04/30/2009 | WO2009026155A3 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
| 04/30/2009 | WO2009022988A3 Vhz for diagnosis and treatment of cancer |
| 04/30/2009 | WO2009019312A3 Anti cd37 antibodies |
| 04/30/2009 | WO2009013619A3 The ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 04/30/2009 | WO2009010957A3 Heparanase c-terminal domain, sequences derived therefrom, substances directed against said domain and uses thereof as modulators of heparanase biological activity |
| 04/30/2009 | WO2008155387A3 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin |
| 04/30/2009 | WO2008140487A3 Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use |
| 04/30/2009 | WO2008110937A3 Antibodies against h5n1 strains of influenza a virus |
| 04/30/2009 | WO2008085794A3 Methods and compositions related to clot binding compounds |
| 04/30/2009 | WO2008083150A3 Methods and vectors for generating asialylated immunoglobulins |
| 04/30/2009 | WO2007103146A3 Truncated proteins as cancer markers |
| 04/30/2009 | WO2007056352A3 Compositions and methods for controlling tissue factor signaling specificity |
| 04/30/2009 | WO2007056047A3 Antibodies, assays and kits to quantitate cartilage destruction |
| 04/30/2009 | WO2007041614A3 Long acting vegf inhibitors and methods of use |
| 04/30/2009 | WO2007040912A3 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/30/2009 | WO2007027916A9 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 04/30/2009 | WO2006127978A3 Compositions and methods for the treatment of cancer |
| 04/30/2009 | WO2006113546A3 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 04/30/2009 | WO2006085938A3 Il-13 binding agents |
| 04/30/2009 | WO2006083964A3 Modified fusion molecules for treatment of allergic disease |
| 04/30/2009 | WO2006060643A3 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 04/30/2009 | WO2006054297A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/30/2009 | WO2006036175A3 Wnt proteins and detection and treatment of cancer |
| 04/30/2009 | WO2006009890A3 Methods and compositions for producing insulin sensitization |
| 04/30/2009 | WO2005120583A3 Method for preventing or treating cardiac hypertrophy |
| 04/30/2009 | US20090111974 Treatment of Liver Cirrhosis and Its Complications |
| 04/30/2009 | US20090111973 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 04/30/2009 | US20090111972 Novel hemopoietin receptor protein, nr12 |
| 04/30/2009 | US20090111970 used to regulate an immune response in an animal; inhibits TF-1 cell proliferation activity |
| 04/30/2009 | US20090111968 Self-assembled proteins and related methods and protein structures |
| 04/30/2009 | US20090111756 Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus |
| 04/30/2009 | US20090111745 Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111146 Antibody Drug |
| 04/30/2009 | US20090111143 Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium |
| 04/30/2009 | US20090111129 Methods and Kits for Detecting Fungal Infection |
| 04/30/2009 | US20090111124 Kinase peptides and antibodies |
| 04/30/2009 | US20090111095 Novel diagnostic kit for malignant melanoma |
| 04/30/2009 | US20090110700 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110686 Antibodies against CCR5 and uses thereof |
| 04/30/2009 | US20090110685 Treatment and prevention of viral infections |
| 04/30/2009 | US20090110684 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/30/2009 | US20090110683 Monoclonal antibodies against activated protein c |
| 04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
| 04/30/2009 | US20090110676 BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders |
| 04/30/2009 | US20090110632 Biological materials and uses thereof |
| 04/30/2009 | DE102005051976B4 Kit für hoch-sensitive Nachweisassays Kit for highly sensitive detection assays |
| 04/30/2009 | CA2703947A1 Therapeutic and diagnostic methods using tim-3 |
| 04/30/2009 | CA2703787A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | CA2703738A1 Monoclonal antibodies against activated unactivated protein c |
| 04/30/2009 | CA2703712A1 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 04/30/2009 | CA2703667A1 Anti-rsv g protein antibodies |
| 04/30/2009 | CA2703329A1 Use of trkb antibodies for the treatment of respiratory disorders |
| 04/30/2009 | CA2703154A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| 04/30/2009 | CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | CA2702938A1 Cancer classification and methods of use |
| 04/30/2009 | CA2702637A1 Fully human anti-vegf antibodies and methods of using |
| 04/30/2009 | CA2702623A1 Use of tenascin-w as a biomarker for colon cancer |